The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiopharma Cred. Regulatory News (BPCR)

Share Price Information for Biopharma Cred. (BPCR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.876
Bid: 0.874
Ask: 0.88
Change: 0.00 (0.00%)
Spread: 0.006 (0.686%)
Open: 0.88
High: 0.88
Low: 0.876
Prev. Close: 0.876
BPCR Live PriceLast checked at -
BioPharma Credit is an Investment Trust

To generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Dividend Declaration

21 Mar 2024 16:05

RNS Number : 8341H
BioPharma Credit PLC
21 March 2024
 

21 March 2024

 

BIOPHARMA CREDIT PLC 

("BIOPHARMA CREDIT" OR THE "COMPANY") 

DIVIDEND DECLARATION

BioPharma Credit PLC (LSE: BPCR), the specialist life sciences debt investor, is pleased to declare an interim dividend in respect of the financial period ending 31 March 2024 of $0.0175 per ordinary share, payable on 30 April 2024 to ordinary shareholders on the register as at 2 April 2024. The ex-dividend date will be 28 March 2024. The Company has chosen to designate the entire amount of this interim dividend as an interest distribution. Shareholders in receipt of such a dividend will be treated for UK tax purposes as though they have received a payment of interest. This will result in a reduction in the corporation tax payable by the Company.

The Company is currently paying and continues to target a 7 cent annual dividend per ordinary share.

The default payment for dividends is in US dollars. However, shareholders can elect to have dividends paid in sterling (GBP) and the option to elect a sterling dividend payment for this dividend will be available to shareholders until 2 April 2024 (the "Election Date").

Further details together with a copy of the Dividend Currency Election Form, which should be sent to Link Group, 10th Floor, Central Square, 29 Wellington Street, Leeds LS1 4DL when completed, will be available on the Group's website shortly at www.bpcruk.com/investor-materials. CREST shareholders must elect via CREST. Further details together with a copy of the Dividend Currency Election Form, which should be sent to Link Group, 10th Floor, Central Square, 29 Wellington Street, Leeds LS1 4DL when completed, will be available on the Group's website shortly at www.bpcruk.com/investor-materials. CREST shareholders must elect via CREST.

Enquiries:

BioPharma Credit plc

via Link Company Matters Limited

Company Secretary

+44 (0) 333 300 1950

Buchanan

David Rydell / Mark Court / Jamie Hooper / Henry Wilson

+44 (0)20 7466 5000

biopharmacredit@buchanan.uk.com

Notes to Editors:

BioPharma Credit PLC is London's only listed specialist investor in debt from the life sciences industry and joined the LSE on 27 March 2017. The Company seeks to provide long-term shareholder returns, principally in the form of sustainable income distributions from exposure to the life sciences industry. The Company seeks to achieve this objective primarily through investments in debt assets secured by royalties or other cash flows derived from the sales of approved life sciences products.

LEI: 213800AV55PYXAS7SY24

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVJBMJTMTTTBJI
Date   Source Headline
16th Sep 20207:05 amRNSAppointment of New Director
16th Sep 20207:00 amRNSHalf-year Report
9th Sep 20204:00 pmRNSLEXICON PHARMACEUTICALS PREPAYMENT
21st Aug 20204:00 pmRNSNet Asset Value(s) and Monthly Factsheet
18th Aug 20203:25 pmRNSNotice of Half Year Results
12th Aug 20203:30 pmRNSDividend Declaration
7th Aug 20207:00 amRNSUPDATES TO THE PORTFOLIO
4th Aug 20204:30 pmRNSHolding(s) in Company
4th Aug 202011:15 amRNSHolding(s) in Company
3rd Aug 20201:15 pmRNSTotal Voting Rights
30th Jul 20204:00 pmRNSSTATEMENT REGARDING LEXICON PHARMACEUTICALS
24th Jul 20203:15 pmRNSHolding(s) in Company
21st Jul 20204:00 pmRNSNet Asset Value(s) and Monthly Factsheet
21st Jul 20207:00 amRNSAMICUS PREPAYMENT
16th Jul 20207:00 amRNSCOMPLETION OF SHARE BUYBACK PROGRAMME
15th Jul 20205:30 pmRNSTransaction in Own Shares
14th Jul 20205:30 pmRNSTransaction in Own Shares
13th Jul 20205:45 pmRNSTransaction in Own Shares
13th Jul 20207:00 amRNSSHARE BUY-BACK PROGRAMME
9th Jul 20205:45 pmRNSDirector/PDMR Shareholding
25th Jun 20203:00 pmRNSResult of AGM
22nd Jun 20207:00 amRNSNet Asset Value(s) and Monthly Factsheet
22nd Jun 20207:00 amRNSActivation of Discount Control Mechanism
19th Jun 20204:30 pmRNSChange of AGM Venue
29th May 20205:30 pmRNSNotice of AGM
28th May 20205:30 pmRNSHolding(s) in Company
26th May 20207:00 amRNSNEW CREDIT FACILITY
22nd May 20204:00 pmRNSNet Asset Value(s) and Monthly Factsheet
14th May 20203:00 pmRNSDividend Declaration
7th May 20205:30 pmRNSDate of Annual General Meeting
27th Apr 202012:30 pmRNSArticles of Association
23rd Apr 20204:00 pmRNSNet Asset Value(s) and Monthly Factsheet
22nd Apr 202012:30 pmRNSDirector/PDMR Shareholding
23rd Mar 20205:40 pmRNSHolding(s) in Company
20th Mar 20204:00 pmRNSNet Asset Value(s) and Monthly Factsheet
10th Mar 20202:00 pmRNSREPLACEMENT: Annual Financial Report
10th Mar 20207:00 amRNSAnnual Financial Report
21st Feb 20204:00 pmRNSNet Asset Value(s) and Monthly Factsheet
20th Feb 20205:00 pmRNSDividend Declaration
17th Feb 202010:10 amRNSNotice of Full Year Results
7th Feb 20207:00 amRNSNEW INVESTMENT
27th Jan 20204:48 pmRNSHolding(s) in Company
22nd Jan 20204:00 pmRNSNet Asset Value(s)
20th Dec 20194:00 pmRNSNet Asset Value(s)
18th Dec 201912:15 pmRNSNew Investment
13th Dec 20192:01 pmRNSCorrection: New Investment
13th Dec 20191:35 pmRNSNew Investment
12th Dec 20192:15 pmRNSHolding(s) in Company
21st Nov 20194:00 pmRNSNet Asset Value(s)
13th Nov 20197:00 amRNSNew Investments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.